Pharmaceutical

Resilience secures funds to enhance production of essential medicine components

National Resilience’s subsidiary Resilience Government Services has received around $17.5m in funding for expanding critical medicine components manufacturing.

Oct 6, 2024 - 04:00
Resilience secures funds to enhance production of essential medicine components
National Resilience’s subsidiary Resilience Government Services has received around $17.5m in funding for expanding critical medicine components manufacturing.
Read the original article

Tags:

Previous Article

BMS receives FDA approval for Opdivo to treat NSCLC

Next Article

A rational design approach to RNA targeting could replace large-scale screening

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: How a now-retracted study got published in the first place, leading to a $3.8 million NIH grant

STAT+: How a now-retracted study got published in the f...

Jun 10, 2023

(Nanatinostat + valganciclovir) by Viracta Therapeutics...

Dec 24, 2023

ODAIA wins $25m funding to boost commercial insights platform for pharma

ODAIA wins $25m funding to boost commercial insights pl...

May 2, 2023